EMT-related gene risk model establishment for prognosis and drug treatment efficiency prediction in hepatocellular carcinoma

被引:1
|
作者
Gao X. [1 ]
Yang C. [1 ,2 ,3 ]
Li H. [1 ,2 ,3 ,4 ]
Shao L. [1 ,2 ,4 ]
Wang M. [1 ,2 ,3 ]
Su R. [1 ]
机构
[1] The First Clinical Medical College, Gansu University of Chinese Medicine, Gansu, Lanzhou
[2] Department of Geriatrics, Affiliated Hospital of Gansu University of Chinese Medicine, Gansu, Lanzhou
[3] Key Laboratory of Traditional Chinese Herbs and Prescription Innovation and Transformation of Gansu Province and Gansu Provincial Traditional Chinese Medicine New Product Innovation Engineering Laboratory, Gansu University of Chinese Medicine, Gansu, Lanzh
[4] Key Laboratory of Dunhuang Medicine and Transformation, Ministry of Education, Gansu University of Chinese Medicine, Gansu, Lanzhou
关键词
D O I
10.1038/s41598-023-47886-z
中图分类号
学科分类号
摘要
This study was designed to evaluate the prognosis and pharmacological therapy sensitivity of epithelial mesenchymal transition-related genes (EMTRGs) that obtained from the EMTome database in hepatocellular carcinoma (HCC) using bioinformatical method. The expression status of EMTRGs were also investigated using the clinical information of HCC patients supported by TCGA database and the ICGC database to establish the TCGA cohort as the training set and the ICGC cohort as the validation set. Analyze the EMTRGs between HCC tissue and liver tissue in the TCGA cohort in the order of univariate COX regression, LASSO regression, and multivariate COX regression, and construct a risk model for EMTRGs. In addition, enrichment pathways, gene mutation status, immune infiltration, and response to drugs were also analyzed in the high-risk and low-risk groups of the TCGA cohort, and the protein expression status of EMTRGs was verified. The results showed a total of 286 differentially expressed EMTRGs in the TCGA cohort, and EZH2, S100A9, TNFRSF11B, SPINK5, and CCL21 were used for modeling. The TCGA cohort was found to have a worse outcome in the high-risk group of HCC patients, and the ICGC cohort confirmed this finding. In addition, EMTRGs risk score was shown to be an independent prognostic factor in both cohorts by univariate and multivariate COX regression. The results of GSEA analysis showed that most of the enriched pathways in the high-risk group were associated with tumor, and the pathways enriched in the low-risk group were mainly associated with metabolism. Patients in various risk groups had varying immunological conditions, and the high-risk group might benefit more from targeted treatments. To sum up, the EMTRGs risk model was developed to forecast the prognosis for HCC patients, and the model might be useful in assisting in the choice of treatment drugs for HCC patients. © 2023, The Author(s).
引用
收藏
相关论文
共 50 条
  • [21] Identification and construction of a 13-gene risk model for prognosis prediction in hepatocellular carcinoma patients
    Cheng, Daming
    Wang, Libing
    Qu, Fengzhi
    Yu, Jingkun
    Tang, Zhaoyuan
    Liu, Xiaogang
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (05)
  • [22] A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinoma
    Zhu Lin
    Zhenkun Huang
    Yunxing Shi
    Yichuan Yuan
    Yi Niu
    Binkui Li
    Yunfei Yuan
    Jiliang Qiu
    Cancer Cell International, 23
  • [23] A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinoma
    Lin, Zhu
    Huang, Zhenkun
    Shi, Yunxing
    Yuan, Yichuan
    Niu, Yi
    Li, Binkui
    Yuan, Yunfei
    Qiu, Jiliang
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [24] Construction and validation of risk model of EMT-related prognostic genes for kidney renal clear cell carcinoma
    Wu, Li Li
    Yuan, Shao-Fei
    Lin, Qiu-Yan
    Chen, Guang-Ming
    Zhang, Wu
    Zheng, Wei-E
    Lin, Hua Long
    JOURNAL OF GENE MEDICINE, 2023, 25 (11):
  • [25] Prognosis prediction model for hepatocellular carcinoma based on autophagy related genes
    Huang, Wei
    Han, Ning
    Du, Lingyao
    Cao, Dan
    Tang, Hong
    Shengwu Yixue Gongchengxue Zazhi/Journal of Biomedical Engineering, 2022, 39 (01): : 120 - 127
  • [26] EMT-related long non-coding RNA in hepatocellular carcinoma: A study with TCGA database
    Zhang, Zonglin
    Wang, Surong
    Liu, Wenqi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 503 (03) : 1530 - 1536
  • [27] Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma
    Tao, Haisu
    Zhang, Yuxin
    Yuan, Tong
    Li, Jiang
    Liu, Junjie
    Xiong, Yixiao
    Zhu, Jinghan
    Huang, Zhiyong
    Wang, Ping
    Liang, Huifang
    Zhang, Erlei
    AGING-US, 2022, 14 (03): : 1473 - 1491
  • [28] Hallmark-guided subtypes of hepatocellular carcinoma for the identification of immune-related gene classifiers in the prediction of prognosis, treatment efficacy, and drug candidates
    Guo, Chengbin
    Tang, Yuqin
    Yang, Zhao
    Li, Gen
    Zhang, Yongqiang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [29] A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma
    Liu, Chang
    Wu, Zhen
    Wang, Liping
    Yang, Qian
    Huang, Ji
    Huang, Jichang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [30] Prediction of hepatocellular carcinoma prognosis based on expression of an immune-related gene set
    He, Yuting
    Dang, Qin
    Li, Jie
    Zhang, Qiyao
    Yu, Xiao
    Xue, Miaomiao
    Guo, Wenzhi
    AGING-US, 2020, 12 (01): : 965 - 977